id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-D-0007-0004,FDA,FDA-2001-D-0007,Biological Product Deviation Reporting for Blood and Plasma Establishments; Guidance for Industry; Availability,Notice,Notice of Availability,2020-03-13T04:00:00Z,2020,3,2020-03-13T04:00:00Z,,2020-03-13T14:56:32Z,2020-05103,0,0,0900006484441d07
FDA-2001-D-0007-0005,FDA,FDA-2001-D-0007,Biological Product Deviation Reporting for Blood and Plasma Establishments Guidance for Industry,Other,Guidance,2020-03-12T04:00:00Z,2020,3,2020-03-12T04:00:00Z,,2024-11-12T23:18:36Z,,1,0,09000064844428e1
FDA-2001-D-0007-0002,FDA,FDA-2001-D-0007,Guidance,Supporting & Related Material,GDL-Guidance,2006-10-20T04:00:00Z,2006,10,,,2008-04-25T01:57:38Z,,0,0,09000064804b4438
FDA-2001-D-0007-0003,FDA,FDA-2001-D-0007,FDA,Notice,NAD-Notice of Availability of Data,2006-10-20T04:00:00Z,2006,10,2006-10-19T04:00:00Z,2007-10-20T03:59:59Z,2008-04-25T01:57:38Z,,0,0,09000064804b443b
FDA-2001-D-0007-0001,FDA,FDA-2001-D-0007,FDA,Notice,NAD-Notice of Availability of Data,2001-08-13T04:00:00Z,2001,8,2001-08-13T04:00:00Z,2001-11-14T04:59:59Z,2008-04-25T01:57:38Z,,0,0,09000064804b4375